Stock Comparison · Live Data
AMGN vs GILD
Side-by-side comparison of Amgen Inc (AMGN), Gilead Sciences Inc (GILD) — live price, market cap, day change, and sector classification.
AMGN vs GILD — which stock is the better buy?
Amgen Inc (AMGN) leads this comparison by market capitalization at $178.10B. GILD is today's top mover with a +0.73% move, while GILD sees the highest trading volume at 3.44M shares.
Whether AMGN vs GILD is the better investment for your portfolio depends on your time horizon, risk tolerance, and existing exposure. ArbibX runs Claude AI across thousands of US stocks daily and surfaces the most actionable picks with confidence scores and target prices. For a personalized analysis on AMGN vs GILD, use the in-app "Ask Claude" assistant — it sees the live prices from this page plus your portfolio context.
Per-stock breakdown
- AMGN — Amgen Inc trades at $322.70, day change -2.16%, biological products, (no diagnostic substances) sector, market cap $178.10B.
- GILD — Gilead Sciences Inc trades at $132.61, day change +0.73%, biological products, (no diagnostic substances) sector, market cap $163.40B.
Frequently asked
Which is the better stock — AMGN vs GILD?
It depends on your goals. Amgen Inc (AMGN) has the larger market cap at $178.10B. Today GILD is the strongest performer (+0.73%). For a qualitative read on each name use the AI Top 15 tab on ArbibX.
What is the current price of AMGN and GILD?
AMGN is trading at $322.70 (-2.16% on the day). GILD is trading at $132.61 (+0.73% on the day). Live prices update every minute on the ArbibX terminal.
How does ArbibX compare stocks?
ArbibX pulls live snapshot data from Polygon.io and pairs it with Claude-powered AI analysis. Comparison pages show price, market cap, day change, sector, and key technicals side by side. The deeper analysis (target prices, signals, risk notes) lives on each ticker's dedicated page.
Not financial advice · For informational purposes only · Data via Polygon.io